• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Latest print issue
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
    • Annual Review
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
IPEM 2018
Unquote
  • Buyouts

IK sells Signature Foods to Pamplona

  • Katharine Hidalgo
  • Katharine Hidalgo
  • 21 December 2020
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

IK Investment Partners has sold chilled food company Signature Foods to Pamplona Capital Management.

The acquirer is currently investing from Pamplona Capital Partners V, which closed on €3bn in July 2017.

Previous funding
AAC acquired Gilde Equity Management Benelux's stake in Salad Signature in May 2012. ING Bank, BNP Paribas Fortis, Rabobank and Belfius provided debt financing for the transaction. Gilde had backed the MBO of Uniq Belgium in November 2006, a transaction valued at €60m. Following the deal, the company was rebranded to Hamal Signature. Fortis Bank and ING provided debt for the initial deal.

Signature Foods

  • DEAL:

    SBO

  • LOCATION:

    Hilversum

  • SECTOR:

    Food products

  • FOUNDED:

    1962

  • TURNOVER:

    €300m

  • STAFF:

    600

  • VENDOR:

    IK Investment Partners

IK invested in Signature Foods in January 2016; during IK's holding period, the company expanded into new products and markets, completing four strategic acquisitions, according to a statement. The GP acquired Signature Foods from its IK VII fund, which closed on €1.4bn in October 2013. The fund has made several realisations to date, including food products company Cérélia Group.

Company
Headquartered in Hilversum, the Netherlands, Signature Foods employs more than 600 people across seven manufacturing sites in the Netherlands, Belgium and Poland. It produces spreads and dips, bites and tapas, and other food products. It generates revenues of more than €300m.

People
IK Investment Partners
– Norman Bremer (partner).
Signature Foods – Erik Bras (CEO).

Advisers
Vendor
– JP Morgan (corporate finance); ING (corporate finance); Allen & Overy (legal); OC&C (operational due diligence); PwC (financial due diligence, tax); Ramboll (environmental due diligence).
Management – Jamieson (corporate finance); Vriman (legal); PwC (tax).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • Exits
  • Benelux
  • Consumer
  • Netherlands
  • Secondary buyout
  • IK Investment Partners
  • Pamplona Capital Management
  • PwC
  • Allen & Overy
  • ING

More on Buyouts

Gaming PCs
Sagard invests in Flight Simulator developer Asobo Studio

Deal is the second for the Sagard NewGen fund, launched in July 2020 with a €300m target

  • Buyouts
  • 21 January 2021
Pharmaceuticals
Baird sells Prescient to BDC

In November 2020, the vendor requested another set of indicative offers from seven or eight bidders

  • Buyouts
  • 21 January 2021
Electricty transformers and substations
Oaktree Capital backs Col Giovanni Paolo

With the GP's support, the company plans to consolidate its market position and boost its international expansion

  • Buyouts
  • 21 January 2021
Optical wires and fibre internet
Heritage Ventures buys ICT specialist Metoda

GP intends to boost the company's growth and double its revenues in the next five years

  • Buyouts
  • 21 January 2021

Latest News

Craig Ferguson of IMCO
  • LPs
LP Profile: IMCO

Managing director Craig Ferguson discusses accelerated deployment activity during the pandemic and plans to scale up the PE allocation by 2025

  • 22 January 2021
The St Basil Cathedral in Moscow
  • Funds
Elbrus holds first close on $260m for third fund – report

Fund has a target of $600m, which it plans to reach by next year, according to Kommersant

  • 22 January 2021
Petri dishes and laboratory glass equipment
  • Early-stage
Alta Life Sciences invests in Inbiomotion

Existing investors including Institut Català de Finances also take part in the financing

  • 22 January 2021
clinical-trial
  • Early-stage
Korys, FPIM et al. in €12m extended series-B for Remynd

Biotech company initially raised €12m in December 2018

  • 22 January 2021
Back to Top

Most read

Craig Ferguson of IMCO
LP Profile: IMCO
The St Basil Cathedral in Moscow
Elbrus holds first close on $260m for third fund – report
Petri dishes and laboratory glass equipment
Alta Life Sciences invests in Inbiomotion
clinical-trial
Korys, FPIM et al. in €12m extended series-B for Remynd
Financial results reveal slump
Eurazeo raises €2.8bn in 2020
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013